{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-004668","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.753636+00:00","generated_at":"2026-05-18T22:25:39.906479+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ZEO launches physician masterclass ahead of Florida's SB-1768 stem cell therapy law","bullets":["Florida's SB-1768, effective July 1, 2025, permits MDs and DOs to offer non-FDA-approved stem cell therapies under strict compliance.","ZEO's Masterclass on June 27, 2025, at NOVA Southeastern University educates physicians on SB-1768 compliance and clinical integration.","Company positions itself as trusted supplier of compliant stem cell products via its FDA-registered facility.","No financial guidance, revenue impact, or clinical trial results included in the announcement."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-004668","json":"https://secwatch.observer/filing/0001829126-25-004668.json","markdown":"https://secwatch.observer/filing/0001829126-25-004668.md","text":"https://secwatch.observer/filing/0001829126-25-004668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625004668/0001829126-25-004668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625004668/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:25:39.906479+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}